DS

Digvijay Singh

Active Director Director DIN 10837928
DIN 10837928 First appointment Nov 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Nov 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Digvijay Singh

Data last updated:

Digvijay Singh is a Director at Curo24 Digital Health Services Private Limited (since 2025) and Director at Swiftly Meds Private Limited (since 2024). The companies operate in Paper.

DIN 10837928
Primary Designation Director
Industry Paper
First Appointment 14 Nov 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Jul 20252025Active
Swiftly Meds Private Limited U21001UP2024PTC211871
Director14 Nov 20242024Active

Board colleagues of Digvijay Singh

Directorship timeline

Open interactive timeline →
Curo24 Digital Health Services Private Limited
Swiftly Meds Private Limited
Premium access

Shareholding and investment profile for Digvijay Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Digvijay Singh

Digvijay Singh currently holds 2 directorships: Curo24 Digital Health Services Private Limited (Director, since 28 Jul 2025); Swiftly Meds Private Limited (Director, since 14 Nov 2024).

Digvijay Singh was first appointed on 14 Nov 2024 as Director at Swiftly Meds Private Limited. The most recent appointment on record is 28 Jul 2025 at Curo24 Digital Health Services Private Limited.

The current boards of Digvijay Singh's companies include Anuj Pratap Singh (Curo24 Digital Health Services Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available